NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
B cells from HD were enriched and incubated with NK cells from HD or patients with B-CLL, with or without Rituximab, for 16 hours. The specific lysis was calculated according to the relative cell counting using flow cytometry. Data shown are mean values of the specific cytotoxicity by NK cells, error bars represent standard errors and significance was determined using Mann-Whitney testing, P < 0.01(**).
Supplementary Figure S7: The genes that have been significantly modified in both patients with B-CLL or SLL.
A list of the 93 genes that are upregulated or downregulated on microarray analysis of NK cells taken from patients with B-CLL or SLL patients compared with HD. This list includes 46 genes which are downregulated in both B-CLL and SLL patients, 36 genes which are upregulated in both B-CLL patients and SLL patients and 11 genes that are differentially regulated in B-CLL and SLL patients. They have been classified using DAVID Gene Functional Classification Tool (https://david.ncifcrf.gov/home.jsp). 38 genes have been identified to be phosphoproteins; 11 genes have been identified to be involved in an intracellular signaling cascade; 9 genes have been identified to be related to regulation of apoptosis and 15 genes have been identified to be related to transcription regulation.
